Dexmedetomidine and Anesthesia.
dc.contributor.author | Sharma, Sudivya | |
dc.contributor.author | Jain, Prashast | |
dc.date.accessioned | 2017-01-30T05:24:34Z | |
dc.date.available | 2017-01-30T05:24:34Z | |
dc.date.issued | 2013-08 | |
dc.description.abstract | The α2-adrenoceptors (ARs) by virtue of their sedative, analgesic, sympatholytic, anesthetic-sparing and hemodynamicstabilizing properties, have been used as an adjunct to local anesthetics for prolongation of effect. Dexmedetomidine a stereoisomer of medetomidine a highly selective α2-adrenergic receptor (AR) agonist with a relatively high ratio of α2/ α1-activity (1620:1 as compared to 220:1 for clonidine). It has recently been introduced in anesthesia practice. It is currently being used for continuous intravenous sedation in the intensive care setting and procedural sedation in nonintubated patients. | en_US |
dc.identifier.citation | Sharma Sudivya, Jain Prashast. Dexmedetomidine and Anesthesia. Indian Journal of Clinical Practice. 2013 Aug; 24(3): 223-225. | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/182596 | |
dc.language.iso | en | en_US |
dc.source.uri | https://medind.nic.in/iaa/t13/i8/iaat13i8p223.pdf | en_US |
dc.subject | Dexmedetomidine | en_US |
dc.subject | α2-2 adrenergic receptor agonist | en_US |
dc.subject | adjuvant | en_US |
dc.subject | analgesic | en_US |
dc.title | Dexmedetomidine and Anesthesia. | en_US |
dc.type | Article | en_US |